Press release

ASICS Strengthens European Innovation Capabilities Through Establishment of ASICS Institute of Sport Science Europe and Partnership with HumanFab

Athlete/Organization Corporate/Marketing
file

file

Left: Mitsuyuki Tominaga, President and COO of ASICS
Right: Dr. Jean-Bernard Fabre, CEO and Founder of HumanFab

[June 16, 2026 – KOBE, JAPAN & AIX-EN-PROVENCE, FRANCE] – ASICS today announced the establishment of the ASICS Institute of Sport Science Europe (ISS Europe), a new research and development function, to further strengthen its research and development capabilities in Europe. Established within ASICS Europe B.V., ISS Europe will contribute locally to ASICS' global R&D efforts by collaborating with European partners, in close alignment with the ASICS Institute of Sport Science in Japan.

As part of this initiative, ASICS has also entered a strategic partnership with HumanFab, a premier sports research and expertise center, to enhance its athlete testing and innovation capabilities in the region, with an initial focus on tennis performance.

This milestone follows the establishment of ASICS Institute of Sport Science America LLC at the end of last year and represents a significant step in the company’s ongoing efforts to expand and strengthen its global R&D network.

This partnership gives ASICS access to HumanFab's state-of-the-art facilities, including one of the world's most advanced indoor tennis court labs — a competition-level environment that enables full-scale motion analysis on a regulation-size court. This allows researchers to capture critical performance data such as ball spin and speed with a level of precision that complements and extends the work of the ASICS Institute of Sport Science in Kobe. The result is deeper insights into elite athlete performance, enabling the future development of next-generation tennis products.

file

HumanFab Facility

“We are incredibly passionate about physiology and biomechanics,” said Dr. Jean-Bernard Fabre, CEO and Founder of HumanFab. “Together with my team of scientists, we are proud to be working with ASICS, who will utilize the cutting-edge technology at our research center to advance the development of future tennis products.”

Europe is one of ASICS' key growth markets and home to many of its contracted professional athletes. By establishing a dedicated research presence in the region, ASICS will strengthen its ability to engage directly with these athletes, enabling richer data acquisition and more responsive product development, bringing the company closer to its founding vision of 'A Sound Mind in a Sound Body.'

“We are greatly honored to have established this partnership with HumanFab,” said Mitsuyuki Tominaga, President and COO of ASICS. “Throughout our history, ASICS has upheld its founding philosophy of ‘Anima Sana in Corpore Sano’ — ‘A Sound Mind in a Sound Body’ — and has been committed to delivering cutting-edge products that support athletes’ performance and well-being. By establishing a testing environment in Europe, we will be able to leverage advanced technologies and integrate real-time athlete data into our research and development activities. This facility will further accelerate our development cycle and help athletes achieve their highest levels of performance and feel.”

As part of the ASICS Global Tennis Summit program, ISS Europe and HumanFab presented their collaboration during a session held at HumanFab on June 14. Researchers from both organizations introduced the initiative and shared early findings from the project. The session also featured an early prototype of a next-generation tennis shoe currently being developed for future launch.

This initiative forms part of ASICS’ broader Global Integrated Enterprise (GIE) approach, under which regional expertise and athlete insights are connected across markets to support sustainable innovation and long-term business growth.

This website uses cookies to improve user experience. By continuing to browse, you agree to the use of cookies. For more information, please refer to the Cookie Policy.